【2024】如何養生？實踐 7 種養生之道，讓氣色更健康！

FDA approves Benlysta | 合法藥品大搜索

FDA approves Benlysta

2020年12月17日—TheFDAhasapprovedbelimumabinintravenousandsubcutaneousformulationsforthetreatmentoflupusnephritisinadultpatientswhoare ...

 FDA approves Benlysta

2020年12月17日 — The FDA has approved belimumab in intravenous and subcutaneous formulations for the treatment of lupus nephritis in adult patients who are ...

閱讀更多

Belimumab lupus nephritis Obinutuzumab lupus nephritis Belimumab as add-on therapy in lupus nephritis Voclosporin Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis Targeting CD38 with daratumumab in refractory systemic lupus erythematosus Belimumab sc NCT01639339 Belimumab lupus nephritis Obinutuzumab lupus nephritis Belimumab as add-on therapy in lupus nephritis Voclosporin Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis Targeting CD38 with daratumumab in refractory systemic lupus erythematosus Belimumab sc NCT01639339 中耳炎耳滴劑 食品及 製藥 代 工廠 華特實業股份有限公司 樂洗塞膜衣錠１２公絲 滅咳康兒童 胃去病副作用 伯 基 葉酸 蒂膚麗ptt
Two-Year | 合法藥品大搜索
Read More
Belimumab in Lupus Nephritis | 合法藥品大搜索
2021年1月14日 — To the Editor: Furie et al. (Sept. 17 issue)1 report the results of the Belimumab International Study in Lupus Nephritis (BLISSLN), a large, ... Read More
Belimumab as Add | 合法藥品大搜索
由 M Ward 著作 · 2020 · 被引用 3 次 — Belimumab as Add-on Therapy in Lupus Nephritis ... Nephritis, the most common serious manifestation of systemic lupus erythematosus (SLE), ... Read More
Belimumab in Lupus Nephritis | 合法藥品大搜索
由 N Oliva-Damaso 著作 · 2021 — Belimumab is a human monoclonal antibody that inhibits the soluble form of a B-​cell survival factor known as BLyS or BAFF. BLyS levels are ... Read More
Belimumab in lupus nephritis | 合法藥品大搜索
由 SJ Allison 著作 · 2020 — The BAFF-neutralizing antibody belimumab is approved for use in patients with SLE, but trials to date have excluded patients with acute, severe ... Read More
Two-Year, Randomized | 合法藥品大搜索
由 R Furie 著作 · 2020 · 被引用 80 次 — In this trial involving patients with active lupus nephritis, more patients who received belimumab plus standard therapy had a primary efficacy ... Read More
European Commission approves Benlysta for adult patients ... | 合法藥品大搜索
2021年5月5日 — Benlysta is the first biologic approved to treat lupus and lupus nephritis, representing a significant new treatment option for patients and ... Read More
FDA approves Benlysta | 合法藥品大搜索
2020年12月17日 — The FDA has approved belimumab in intravenous and subcutaneous formulations for the treatment of lupus nephritis in adult patients who are ... Read More
相關資訊整理

【山喜多注射劑500毫克(法國廠)】與cyclosporin和類固醇合併使用，以預防腎臟、心臟和肝臟移植之器官排斥。

藥品名稱:山喜多注射劑500毫克(法國廠)許可證字號:衛部藥輸字第027227號許可證種類:製　劑適應症:與cyclosporin和類固醇合併...

【山喜多注射劑500毫克】與Cyclosporin和類固醇合併使用，以預防腎臟、心臟和肝臟移植之器官排斥。

藥品名稱:山喜多注射劑500毫克許可證字號:衛署藥輸字第024623號許可證種類:製　劑適應症:與Cyclosporin和類固醇合併使用，以...

【安/腸衣錠】消炎、消腫

藥品名稱:安/腸衣錠許可證字號:內衛藥製字第000911號許可證種類:製　劑適應症:消炎、消腫劑型:藥品類別:須經醫師指示使用主...

【生利新－Ｎ凍晶注射劑】坐骨神經痛、三叉神經痛、神經炎、關節炎、骨關節炎、帶狀？疹

藥品名稱:生利新－Ｎ凍晶注射劑許可證字號:內衛藥製字第003127號許可證種類:製　劑適應症:坐骨神經痛、三叉神經痛、神經炎、...

【愛體康錠】維生素Ｂ１、Ｂ６、Ｂ１２及Ｅ缺乏症。

藥品名稱:愛體康錠許可證字號:衛署藥輸字第022254號許可證種類:製　劑適應症:維生素Ｂ１、Ｂ６、Ｂ１２及Ｅ缺乏症。劑型:藥...

【去水腫腸衣錠】消除水腫、減輕水腫性靜脈曲張症

藥品名稱:去水腫腸衣錠許可證字號:內衛藥輸字第002546號許可證種類:製　劑適應症:消除水腫、減輕水腫性靜脈曲張症劑型:藥品...

【喜多民針】維持肝臟機能、營養失調、外科手術前後

藥品名稱:喜多民針許可證字號:內衛藥輸字第004036號許可證種類:製　劑適應症:維持肝臟機能、營養失調、外科手術前後劑型:藥...